BACKGROUND: Breast metastases from extra mammary tumors are extremely rare. CASE REPORT: Here we report the case of a 50-year-old female with histologically-confirmed gastric cancer metastasis to the breast who was adequately treated with loco-regional hyperthermia plus standard second-line chemotherapy (paclitaxel plus ramucirumab). The best response achieved was a relatively long disease stabilization. CONCLUSION: Chemotherapy plus regional hyperthermia has been shown to have a synergistic antitumor effect and possible favorable immunomodulatory effects. Such an approach merits further investigation especially for the treatment of rare superficial metastatic sites.
Lucchetti, J., Formica, V., Giuliano, G., Coletta, D., Gargano, L., Morosetti, D., et al. (2018). Case report of a patient with breast metastasis from gastric cancer treated with paclitaxel and ramucirumab plus regional hyperthermia. ANTICANCER RESEARCH, 38(11), 6561-6564 [10.21873/anticanres.13022].
Case report of a patient with breast metastasis from gastric cancer treated with paclitaxel and ramucirumab plus regional hyperthermia
Formica V.;Morosetti D.;Sileri P.;Palmieri G.;Roselli M.
2018-01-01
Abstract
BACKGROUND: Breast metastases from extra mammary tumors are extremely rare. CASE REPORT: Here we report the case of a 50-year-old female with histologically-confirmed gastric cancer metastasis to the breast who was adequately treated with loco-regional hyperthermia plus standard second-line chemotherapy (paclitaxel plus ramucirumab). The best response achieved was a relatively long disease stabilization. CONCLUSION: Chemotherapy plus regional hyperthermia has been shown to have a synergistic antitumor effect and possible favorable immunomodulatory effects. Such an approach merits further investigation especially for the treatment of rare superficial metastatic sites.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
